Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Atar

Showing results (291-300 of 405) with videos related to

Pageof 41
Sort By:
Cerebrovascular Diseases Extra|February 7, 2020
Biomarkers Associated with Atrial Fibrillation in Patients with Ischemic Stroke: A Pilot Study from the NOR-FIB StudyAnna Tancin Lambert, Xiang Y Kong, Barbara Ratajczak-Tretel, et al.
Cardiology|June 27, 2017
Administration of the Mitochondrial Permeability Transition Pore Inhibitor, TRO40303, prior to Primary Percutaneous Coronary Intervention, Does Not Affect the Levels of Pro-Inflammatory Cytokines or Acute-Phase ProteinsNoreen Butt, Lena K Bache-Mathiesen, Jan Erik Nordrehaug, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|March 27, 2025
Management of patients with congenital bleeding disorders and cardiac indications for antithrombotic therapyDan Atar, Christophe Vandenbriele, Stefan Agewall, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 29, 2023
The Danish-Norwegian randomized trial on beta-blocker therapy after myocardial infarction: Design, rationale, and baseline characteristicsAnna Meta Dyrvig Kristensen, John Munkhaugen, Sigrun Halvorsen, et al.
International Journal of Cardiology|March 5, 2019
Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure - A multicenter propensity score matched analysisTobias Täger, Hanna Fröhlich, Morten Grundtvig, et al.
International Journal of Cardiology. Heart & Vasculature|November 29, 2023
Rhythm versus rate control in patients with newly diagnosed atrial fibrillation - Observations from the GARFIELD-AF registryMarita Knudsen Pope, Trygve S Hall, Saverio Virdone, et al.
Research and Practice in Thrombosis and Haemostasis|April 17, 2025
Exercise capacity, dyspnea, and quality of life 6 months after exercise-based rehabilitation in patients with persistent dyspnea following pulmonary embolismStacey Haukeland-Parker, Øyvind Jervan, Waleed Ghanima, et al.
Journal of the American College of Cardiology|February 24, 2009
Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trialDan Atar, Peter Petzelbauer, Jürg Schwitter, et al.
European Heart Journal|May 25, 2026
Outcomes in the BETAMI-DANBLOCK trial compared with a Norwegian nationwide myocardial infarction populationAnna Meta Dyrvig Kristensen, Jarle Jortveit, Therese Holmager, et al.
International Journal of Cardiology|March 27, 2017
Statins attenuate but do not eliminate the reverse epidemiology of total serum cholesterol in patients with non-ischemic chronic heart failureHanna Fröhlich, Nandita Raman, Tobias Täger, et al.
Pageof 41

Showing results (291-300 of 405) with videos related to

Sort By:
Pageof 41
Cerebrovascular Diseases Extra|February 7, 2020
Biomarkers Associated with Atrial Fibrillation in Patients with Ischemic Stroke: A Pilot Study from the NOR-FIB StudyAnna Tancin Lambert, Xiang Y Kong, Barbara Ratajczak-Tretel, et al.
Cardiology|June 27, 2017
Administration of the Mitochondrial Permeability Transition Pore Inhibitor, TRO40303, prior to Primary Percutaneous Coronary Intervention, Does Not Affect the Levels of Pro-Inflammatory Cytokines or Acute-Phase ProteinsNoreen Butt, Lena K Bache-Mathiesen, Jan Erik Nordrehaug, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|March 27, 2025
Management of patients with congenital bleeding disorders and cardiac indications for antithrombotic therapyDan Atar, Christophe Vandenbriele, Stefan Agewall, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 29, 2023
The Danish-Norwegian randomized trial on beta-blocker therapy after myocardial infarction: Design, rationale, and baseline characteristicsAnna Meta Dyrvig Kristensen, John Munkhaugen, Sigrun Halvorsen, et al.
International Journal of Cardiology|March 5, 2019
Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure - A multicenter propensity score matched analysisTobias Täger, Hanna Fröhlich, Morten Grundtvig, et al.
International Journal of Cardiology. Heart & Vasculature|November 29, 2023
Rhythm versus rate control in patients with newly diagnosed atrial fibrillation - Observations from the GARFIELD-AF registryMarita Knudsen Pope, Trygve S Hall, Saverio Virdone, et al.
Research and Practice in Thrombosis and Haemostasis|April 17, 2025
Exercise capacity, dyspnea, and quality of life 6 months after exercise-based rehabilitation in patients with persistent dyspnea following pulmonary embolismStacey Haukeland-Parker, Øyvind Jervan, Waleed Ghanima, et al.
Journal of the American College of Cardiology|February 24, 2009
Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trialDan Atar, Peter Petzelbauer, Jürg Schwitter, et al.
European Heart Journal|May 25, 2026
Outcomes in the BETAMI-DANBLOCK trial compared with a Norwegian nationwide myocardial infarction populationAnna Meta Dyrvig Kristensen, Jarle Jortveit, Therese Holmager, et al.
International Journal of Cardiology|March 27, 2017
Statins attenuate but do not eliminate the reverse epidemiology of total serum cholesterol in patients with non-ischemic chronic heart failureHanna Fröhlich, Nandita Raman, Tobias Täger, et al.
Pageof 41